Shanghai Aohua Photoelectricity Endoscope Co. Ltd. Class A
SSSE:68821225.58
CNY
+0.23
(+0.91%)
ISIN
CNE100004ZJ5
Return %
Stock
S&P 500
1Y
-46.07
14.20
3Y
-58.32
81.12
5Y
- -
68.34
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Quarterly Revenue
CNY
•
in mil. unless spec.Quarterly Earnings Per Share
CNY
•
in mil. unless spec.Quarterly Dividends Per Share
CNY
•
in mil. unless spec.Company Description
- CEO
- Xiao Zhou Gu
- Full Time Employees
- 1,159
- Sector
- Electronic technology
- Industry
- Electronic equipment/Instruments
- Address
- Shanghai China
- IPO Date
- Nov 15, 2021
- Website
- aohua.com
- Similar Companies
- Business
- Shanghai Aohua Photoelectricity Endoscope Co., Ltd. is a China-based medical device company engaged in the research, development, manufacturing, and commercialization of flexible electronic endoscopy systems, diagnostic visualization equipment, and related therapeutic consumables. The company operates through two primary business segments: Endoscopic Equipment and Medical Consumables. Its core product portfolio comprises high-definition electronic endoscopy systems, including the flagship AQ-400 3D Ultra HD, AQ-300 4K UHD, AQ-200 Elite, AQ-150 Pro, AQ-120, and AQL-200L platforms; flexible video endoscopes, including high-definition gastroscopes, optical zoom colonoscopes, duodenoscopes, bronchoscopes, laryngoscopes, and choledochoscopes; specialized peripheral apparatus, including multi-wavelength LED light sources, image processors, endoscopic carbon dioxide insufflators, irrigation pumps, and automated leakage testers; endoscopic diagnosis and treatment consumables, including non-vascular stents, biopsy forceps, and surgical accessories; and specialized veterinary endoscopic imaging systems. The company integrates proprietary diagnostic visualization technologies, such as Compound Band Imaging optical staining and Hemoglobin Enhancement, across its equipment line to assist physicians in early mucosal cancer and lesion detection. Its products serve clinical departments including gastroenterology, pulmonology, otorhinolaryngology, hepatobiliary surgery, urology, and emergency medicine in hospitals and healthcare facilities across China, as well as in international markets spanning Europe, Latin America, the Middle East, and the Asia-Pacific region. In recent developments, the company received regulatory approval from the National Medical Products Administration for its next-generation AQ-400 3D Ultra HD endoscopy system, integrating hyperspectral optical feedback and extended depth of field imaging capabilities. The company has also accelerated the commercial deployment of its AQ-300 4K UHD platform across tertiary medical institutions and expanded its global medical training partnerships and export distribution channels. Founded on October 27, 1994, Shanghai Aohua Photoelectricity Endoscope Co., Ltd. is headquartered in Shanghai, China.